latest news releases from the newsroom
StockPickReport: Buy Ratings for Pfizer, Sprint FON, Bank of America, and ATI Technologies from StockPickReport
SHREVEPORT, La., May 19, 2005 (PRIMEZONE) -- StockPickReport.Com (IARD #119079, http://www.stockpickreport.com - the web's only non-mainstream stock rating service), rates Pfizer Inc., Sprint FON Group, Bank Of America Corp., ATI Technologies Inc.
CDMA Development Group
CDMA Development Group Comments on the Proposed Allocation of Spectrum in India
COSTA MESA, Calif., May 19, 2005 (PRIMEZONE) -- The CDMA Development Group (CDG) (www.cdg.org) today acknowledged TRAI's recommendations which represent a major step towards rectifying imbalances in spectrum allocation and accelerating the introduction of IMT-2000 (3G) services in India. The CDMA industry supports the TRAI proposal to allocate additional 800 MHz spectrum to CDMA operators. The CDG also urges TRAI and the government of India to continue to promote policies that embrace the concepts of technology and service neutrality and spectrum flexibility to ensure the long-term growth of mobile services in India.
ATA Airlines, Inc.
Ambassadair Travel Club Engages Adelphi Capital to Launch National Search for Buyer
INDIANAPOLIS, May 19, 2005 (PRIMEZONE) -- Ambassadair Travel Club, the nation's largest travel club with nearly 30,000 member families, today announces that, subject to U.S. Bankruptcy Court approval, it has engaged Adelphi Capital LLC of Washington, D.C. to seek a buyer. Ambassadair is currently a subsidiary of ATA Holdings Corp. (Pink Sheets:ATAHQ). Ambassadair was the founding division that launched ATA Airlines, Inc. in 1973.
Greystone Medical Group, Inc.
FDA Clears Greystone Medical Group's Epi-Max for Sale in the U.S.
MEMPHIS, Tenn., May 19, 2005 (PRIMEZONE) -- Greystone Medical Group announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market and sell Epi-Max(r), a wound care product created for the treatment of diabetic skin ulcers and other conditions. The FDA cleared Epi-Max(r) as a combination product, one of the few advanced wound care products that contains both a drug and a device.
Cord Blood America
Cord Blood America Retains AGORA Investor Relations
LOS ANGELES, May 19, 2005 (PRIMEZONE) -- Cord Blood America, Inc. (OTCBB:CBAI), an umbilical cord blood stem cell preservation company, is pleased to announce it has retained the services of AGORA Investor Relations Corp. ("AGORA") (http://www.AgoraIR.com) to provide investor relations services.